PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $537,510 | -32.3% | 41,000 | -42.3% | 0.06% | -26.8% |
Q1 2023 | $793,780 | +32.6% | 71,000 | 0.0% | 0.08% | -4.7% |
Q4 2022 | $598,530 | -81.0% | 71,000 | -19.0% | 0.09% | -82.5% |
Q3 2021 | $3,152,000 | -16.2% | 87,612 | +2.8% | 0.49% | -15.1% |
Q2 2021 | $3,761,000 | – | 85,250 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
Miura Global Management | 570,000 | $25,148,000 | 4.59% |
Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |